XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net loss $ (2,460,489) $ (1,322,861)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 18,264 22,557
Stock compensation expense 148,100
Financing fee   380,000
Gain on debt settlement (130,430) (2,920)
Amortization of debt discount 918,640 145,632
Change in derivative liability (326,539) 12,980
Changes in operating assets and liabilities:    
(Increase) decrease in right of use asset (100,511) 177,745
(Decrease) increase in lease liability 172,325 (175,172)
(Increase) decrease in accounts receivable (617,362) (1,113,760)
(Increase) decrease in prepayments (1,137,464) (194,306)
(Increase) decrease in equity method investment 13,650
(Increase) decrease in other assets 673,030
(Increase) decrease in inventory 349,126 (65,757)
(Decrease) increase in accounts payable (1,041,509) 44,955
Other (Decrease) increase in accrued expenses (422,020) 171,619
Other (Decrease) increase in accrued interest 104,694
Other (Decrease) increase in other payables - related party (705,560)
Other (Decrease) increase in customer deposits 715,473 (24,040)
Net cash used in operating activities (3,842,232) (1,929,678)
Cash Flows from Investing Activities    
Cash acquired from consolidation of Shuya 49,495
Payment to Heze Hongyuan Natural Gas Co (838,090)
Investment in Shuya (550,644)
Purchase of intangible assets (3,802)
Purchase of property and equipment (31,582)
Net Cash provided by investing activities 14,111 (1,388,734)
Cash Flows from Financing Activities    
Proceeds from notes payable and lines of credit 1,544,920 1,677,300
Proceeds from warrant exercise 693,603  
Payments on notes payables and lines of credit (1,463,049) (626,242)
Loan receivable (14,220)
Stock issued for cash 3,145,244 1,493,945
Net Cash provided by financing activities 3,906,498 2,545,003
Foreign currency translation 36,165 (243,136)
Net Increase (decrease) in cash and cash equivalents 114,542 (1,016,545)
Cash and cash equivalents at beginning of period 149,272 1,192,316
Cash and Cash Equivalents at End of Period 263,814 175,771
Supplemental Cash flow information:    
Interest paid 263,053 331,177
Taxes paid
Supplemental Non-Cash Disclosure in Investing and Financing activities    
Discounts on new notes 239,800 437,004
Universal convertible note principal and accrued interest conversion 666,250
Warrants issued in conjunction for convertible notes payable 609,617
Shares issued for warrants 261,639 240,824
Shares issued for debt conversion conversions $ 1,548,904